Cofoe Medical Technology Co.,Ltd.

Yes. Cofoe Medical Technology (1187) has been listed on the Hong Kong Stock Exchange since 2026, in the Medical - Specialties industry, and Indian residents can buy it through Paasa. You fund the account from your Indian bank under the RBI's Liberalised Remittance Scheme and the money is converted to US dollars and then to HKD. Shares are held in your own name at Interactive Brokers, segregated from Paasa's own assets.

One Cofoe Medical Technology share is HK$29.56 — about ₹362 at an HKD/INR rate of 12.25 on 24 Sep 2026. Both the Cofoe Medical Technology price and the rupee rate move during the day, so the rupee cost changes with them.

Remit up to $250,000 per financial year under the RBI's Liberalised Remittance Scheme (LRS). Banks collect 20% tax at source on LRS remittances above ₹10 lakh in a financial year; the TCS is adjustable against your income-tax liability. FX and the LRS declaration are handled by your bank when you fund your account.

Many Hong Kong listings trade in board lots, so the smallest order is one lot rather than one share.

Hong Kong generally does not levy capital gains tax on non-resident individual investors for HKEX-listed stocks, so the tax is an India-side one. Gains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate. The gain is computed in rupees using the HKD/INR rate on the purchase and the sale date, so the rupee move counts alongside the Cofoe Medical Technology price. Paasa issues a capital-gains statement for your return.

Yes. Cofoe Medical Technology pays a dividend — the most recent was HK$0.70 per share, about ₹8.52. Dividends are taxed at your slab rate in India. Paasa's dividend report covers each payment.

The Hong Kong Stock Exchange trades 7:00 am – 1:30 pm IST in Indian time. It also halts for lunch, 9:30 am – 10:30 am IST. Orders can only execute during that window.

Cofoe Medical Technology trades on the Hong Kong Stock Exchange in HKD, but the company is domiciled in China. Cofoe Medical Technology trades as an ordinary share listed directly in Hong Kong, not a depositary receipt. Your India-side capital-gains treatment is the same either way.

Yes. Foreign shares held on 31 March must be reported in Schedule FA of your Indian income-tax return. Paasa gives you a Schedule FA-ready statement listing your Cofoe Medical Technology holding, its cost and its closing value.

You sell during market hours (7:00 am – 1:30 pm IST) and the proceeds settle in HKD in your Paasa account. From there you can hold the balance, reinvest, or repatriate. Funds can be withdrawn in any currency to any bank account in your own name. Whether the sale is short- or long-term is decided by the 24-month holding period.